A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Pfizer Inc stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 3,644,811 shares of PFE stock, worth $102 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,644,811
Previous 4,911,490 25.79%
Holding current value
$102 Million
Previous $141 Million 28.47%
% of portfolio
0.23%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $32.8 Million - $37.7 Million
-1,266,679 Reduced 25.79%
3,644,811 $101 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $6.77 Million - $8.79 Million
-259,002 Reduced 5.01%
4,911,490 $141 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $4.47 Million - $5.22 Million
-139,253 Reduced 2.62%
5,170,492 $172 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $3.61 Million - $4.18 Million
-100,078 Reduced 1.85%
5,309,745 $195 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $5.34 Million - $6.95 Million
135,492 Added 2.57%
5,409,823 $221 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $6.52 Million - $8.51 Million
156,088 Added 3.05%
5,274,331 $270 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $2.93 Million - $3.58 Million
-67,028 Reduced 1.29%
5,118,243 $224 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $34.2 Million - $40.5 Million
734,365 Added 16.5%
5,185,271 $272 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $872,361 - $1.08 Million
19,068 Added 0.43%
4,450,906 $230 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $1.26 Million - $1.86 Million
30,429 Added 0.69%
4,431,838 $262 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $3.41 Million - $4.39 Million
-86,994 Reduced 1.94%
4,401,409 $189 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $30.3 Million - $34.3 Million
-842,734 Reduced 15.81%
4,488,403 $176 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $19.3 Million - $21.8 Million
-576,667 Reduced 9.76%
5,331,137 $194 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $4.97 Million - $6.32 Million
-148,570 Reduced 2.45%
5,907,804 $217 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $440,086 - $516,322
13,861 Added 0.23%
6,056,374 $222 Million
Q2 2020

Sep 11, 2020

BUY
$30.12 - $36.54 $25.7 Million - $31.2 Million
852,662 Added 16.43%
6,042,513 $198 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $36.5 Million - $44.2 Million
-1,210,522 Reduced 18.91%
5,189,851 $198 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $13 Million - $18.6 Million
481,971 Added 8.14%
6,400,373 $209 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $858,882 - $974,722
26,090 Added 0.44%
5,918,402 $232 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $16.8 Million - $21.8 Million
516,560 Added 9.61%
5,892,312 $213 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $9.77 Million - $11 Million
264,216 Added 5.17%
5,375,752 $233 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $8.36 Million - $9.19 Million
-222,953 Reduced 4.18%
5,111,536 $216 Million
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $1.6 Million - $1.83 Million
41,626 Added 0.79%
5,334,489 $233 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $271 Million - $328 Million
-7,852,582 Reduced 59.74%
5,292,863 $233 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $6.92 Million - $7.38 Million
-209,859 Reduced 1.57%
13,145,445 $477 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $1.34 Million - $1.55 Million
41,867 Added 0.31%
13,355,304 $474 Million
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $1.74 Million - $1.85 Million
-52,342 Reduced 0.39%
13,313,437 $482 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $414 Million - $456 Million
13,365,779
13,365,779 $477 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.